Abstract
Purpose of Review
Hypertension remains to be a major contributor to global morbidity and mortality. Despite a plethora of pharmacological options available, an abundance of patients have uncontrolled blood pressure thus creating the need for additional strategies, including non-pharmacologic approaches. In this review, we discuss the antihypertensive effect of slow and deep respiration by increasing baroreflex sensitivity.
Recent Findings
Asking patients to carry out paced breathing sessions unaccompanied by a personal coach or unaided by a device may be unfeasible. Among proposed breathing techniques, RESPeRATE is a US Food and Drug Administration–certified device that assists slow breathing. In this review, we consider the mechanisms through which guided breathing mechanisms may impact on blood pressure control and alternative techniques.
Summary
Guided breathing techniques along with lifestyle therapies may be helpful as a first step for patients with mild hypertension and prehypertension who do not suffer from cardiovascular disease, renal disease, or diabetes. Drug therapy must be considered after a couple of months if non-pharmacological therapy was unsuccessful. Device-guided paced breathing (DGB) may be recommended for those who cannot obtain full control of their hypertension with medical therapy alone or cannot tolerate potential side effects of pharmacologic treatment. Also, patients with well-controlled hypertension who may wish to try to reduce medication burden may be candidates for DGB. Patients with white coat or labile hypertension who are interested in biofeedback techniques could also be considered.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, DW MK, Tremblay G, Mc Lean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, PA MF, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie R, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2015;31(5):549–68. doi:10.1016/j.cjca. 2015.02.016.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.
He FJ, Li J, Mac Gregor GA. Ef fect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomized trials. BMJ. 2013;346:f1325.
Park YM, Steck SE, Fung TT, Zhang J, Hazlett LJ, Han K, Merchant AT. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes. Int J Obes. 2016;40(10):1541–9.
• Authors/Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart Vander Worp H, Van Dis I, Verschuren WM. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;252:207–74. doi:10.1016/j.atherosclerosis. 2016.05.037.
Millar PJ, McGowanCL CVA, Araujo CG, Swaine IL. Evidence for the role of isometric exercise training in reducing blood pressure: potential mechanisms and future directions. Sports Med. 2014;44(3):345–56.
Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens. 2015;28(3):355–61.
de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57(5):898–902. doi:10.1161/HYPERTENSIONAHA.110.168948.
• Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015;116(6):1074–95. doi:10.1161/CIRCRESAHA.116.303603. This review discusses new drugs and interventional treatments in resistant hypertension
• NgFL SM, Mahfoud F, Pathak A, Lobo MD. Device-based therapy for hypertension. Curr Hypertens Rep. 2016;18(8):61. doi:10.1007/s11906-016-0670-5. This review studies seven novel invasive devices employed in resistant hypertension treatment
•• Elliott WJ, Izzo JL. Device-guided breathing to lower blood pressure. Case Report and Clinical Overview. 2006;8(3):23. The first meta-analysis of all clinical trials that evaluates the efficacy of Resperate, demonstrating positive therapeutic effect in hypertensive patients
Gavish B. Device-guided breathing in the home setting: technology, performance and clinical outcomes. Biol Psychol. 2010;84(1):150–6.
Lehrer PM, Vaschillo E, Vaschillo B, Lu SE, Eckberg DL, Edelberg R, Shih WJ, Lin Y, Kuusela TA, Tahvanainen KU, Hamer RM. Heart rate variability biofeedback increases baroreflex gain and peak expiratory flow. Psychosom Med. 2003;65(5):796–805.
Joseph CN, Porta C, Casucci G, Casiraghi N, Maffeis M, Rossi M, et al. Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in essential hypertension. Hypertension. 2005;46(4):714–8.
Reyes del Paso GA, Cea JI, González-Pinto A, Cabo OM, Caso R, Brazal J, et al. Short-term effects of a brief respiratory training on baroreceptor cardiac reflex function in normotensive and mild hypertensive subjects. Appl Psychophysiol Biofeedback. 2006;31(1):37–49.
Schelegle ES, Green JF. An overview of the anatomy and physiology of slowly adapting pulmonary stretch receptors. Respir Physiol. 2001;125(1–2):17–31.
Lin G, Xiang Q, Fu X, Wang S, Wang S, Chen S, Shao L, Zhao Y, Wang T. Heart rate variability biofeedback decreases blood pressure in prehypertensive subjects by improving autonomic function and baroreflex. J Altern Complement Med. 2012;18(2):143–52. doi:10.1089/acm.2010.0607.
•• Sharma M, Frishman WH, Gandhi K. RESPeRATE: nonpharmacological treatment of hypertension. Cardiol Rev. 2011;19(2):47–51. doi:10.1097/CRD.0b013e3181fc1ae6. An excellent review that discusses the effects of paced breathing on blood pressure regulation.
Meuret AE, Wilhelm FH, Roth WT. Respiratory biofeedback-assisted therapy in panic disorder. J Clin Psychol. 2004 Feb;60(2):197–207.
Giardino ND, Chan L, Borson S. Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: preliminary findings. Appl Psychophysiol Biofeedback. 2004;29(2):121–33.
Harada D, Asanoi H, Takagawa J, Ishise H, Ueno H, Oda Y, Goso Y, Joho S, Inoue H. Slow and deep respiration suppresses steady-state sympathetic nerve activity in patients with chronic heart failure: from modeling to clinical application. Am J Physiol Heart Circ Physiol. 2014;307(8):H1159–68. doi:10.1152/ajpheart.00109.2014.
• RESPERATE to lower blood pressure. http://www.resperate.com/. Accessed 24 Nov 2016. Information about the device from the manufacturer.
• Landman GW, Drion I, van Hateren KJ, van Dijk PR, Logtenberg SJ, Lambert J, et al. Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trial. JAMA Intern Med. 2013;173(14):1346–50. doi:10.1001/jamainternmed.2013.6883. This recent study establishes that RESPERATE does not improve BP in hypertensive diabetic patients
Huang AJ, Subak LL. What constitutes an adequate evaluation of device-guided breathing? JAMA Intern Med. 2014;174(4):637. doi:10.1001/jamainternmed.2013.13791.
• Howorka K, Pumprla J, Tamm J, Schabmann A, Klomfar S, Kostineak E, et al. Effects of guided breathing on blood pressure and heart rate variability in hypertensive diabetic patients. Auton Neurosci. 2013;179(1–2):131–7. doi:10.1016/j.autneu. 2013.08.065. This recent study demonstrates that RESPERATE improves BP in well controlled hypertensive diabetic patients
Wojcicki JM, Geissler JD, Stokes CW, Heyman MB, Tran CT. The use of the RESPeRATE device to lower blood pressure in inner city obese adolescents and children: a pilot feasibility study. High Blood Press Cardiovasc Prev. 2013;20(2):89–92. doi:10.1007/s40292-013-0014-3.
• Harada D, Asanoi H, Takagawa J, Ishise H, Ueno H, Oda Y, Goso Y, Joho S, Inoue H. Slow and deep respiration suppresses steady-state sympathetic nerve activity in patients with chronic heart failure: from modeling to clinical application. Am J Physiol Heart Circ Physiol. 2014;15(307(8)):H1159–68. This recent trial demonstrates that DGB suppresses MSNA in patients with heart failure
de Barros S, da Silva GV, de Gusmão JL, de Araujo TG, Mion D Jr. Reduction of sympathetic nervous activity with device-guided breathing. J Clin Hypertens (Greenwich). 2014;16(8):614–5.
• Drozdz T, Bilo G, Debicka-Dabrowska D, Klocek M, Malfatto G, Kielbasa G, Styczkiewicz K, Bednarek A, Czarnecka D, Parati G, Kawecka-Jaszcz K. Blood pressure changes in patients with chronic heart failure undergoing slow breathing training. Blood Press. 2016;25(1):4–10. This recent trial demonstrates that DGB does not affect the prevalence of OH in heart failure
•• Cernes R, Zimlichman R. RESPeRATE: the role of paced breathing in hypertension treatment. J Am Soc Hypertens. 2015;9(1):38–47. doi:10.1016/j.jash. 2014.10.002. This systematic review of all available clinical trials finds a positive effect of paced breathing and recommends this approach in hypertensive patients
Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Breathing-control lowers blood pressure. J Hum Hypertens. 2001;15(4):263–9.
Meles E, Giannattasio C, Failla M, Gentile G, Capra A, Mancia G. Nonpharmacologic treatment of hypertension by respiratory exercise in the home setting. Am J Hypertens. 2004;17(4):370–4.
Rosenthal T, Alter A, Peleg E, Gavish B. Device-guided breathing exercises reduce blood pressure: ambulatory and home measurements. Am J Hypertens. 2001;14(1):74–6.
Bae JH, Kim JH, Choe KH, Hong SP, Kim KS, Kim CH, et al. Blood pressure change following 8-week, 15-minute daily treatment with paced breathing guided by a device: a Korean multi-center study. J Clin Hypertens. 2006;8(5):86.
Anderson DE, Mc Neely JD, Windham BG. Regular slow-breathing exercise effects on blood pressure and breathing patterns at rest. Hum Hypertens. 2010;24(12):807–13. doi:10.1038/jhh. 2010.18.
Elliot WJ, Izzo JL, White WB, Rosing DR, Snyder CS, Alter A, et al. Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens (Greenwich). 2004;6(10):553–9.
Viskoper R, Shapira I, Priluck R, Mindlin R, Chornia L, Laszt A, et al. Nonpharmacologic treatment of resistant hypertensives by device-guided slow breathing exercises. Am J Hypertens. 2003;16(6):484–7.
Schein MH, Gavish B, Herz M, Rosner-Kahana D, Naveh P, Knishkowy B, et al. Treating hypertension with a device that slows and regularizes breathing: a randomized, double-blind controlled study. J Hum Hypertens. 2001;15(4):271–8.
Altena MR, Kleefstra N, Logtenberg SJ, Groenier KH, Houweling ST, Bilo HJ. Effect of device-guided breathing exercises on blood pressure in patients with hypertension: a randomized controlled trial. Blood Press. 2009;18(5):273–9. doi:10.3109/08037050903272925.
Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Bilo HJ. Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial. J Hypertens. 2007;25(1):241–6.
Schein MH, Gavish B, Baevsky T, Kaufman M, Levine S, Nessing A, et al. Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial. J Hum Hypertens. 2009;23(5):325–31.
Oneda B, Ortega KC, Gusmão JL, Araújo TG, Mion D. Sympathetic nerve activity is decreased during device-guided slow breathing. Hypertens Res. 2010;33(7):708–12. doi:10.1038/hr.2010.74.
Bertisch SM, Schomer A, Kelly EE, Baloa LA, Hueser LE, Pittman SD, et al. Device-guided paced respiration as an adjunctive therapy for hypertension in obstructive sleep apnea: a pilot feasibility study. Appl Psychophysiol Biofeedback. 2011;36(3):173–9. doi:10.1007/s10484-011-9158-x.
• Landman GW, van Hateren KJ, van Dijk PR, Logtenberg SJ, Houweling ST, Groenier KH, Bilo HJ, Kleefstra N. Efficacy of device-guided breathing for hypertension in blinded, randomized, active-controlled trials: a meta-analysis of individual patient data. JAMA Intern Med. 2014;174(11):1815–21. doi:10.1001/jamainternmed. 2014.4336. A recent meta-analysis that criticizes the DGB trials sponsored by manufacturer and appreciates only three studies. DGB as a routine treatment is not recommended
Mahtani KR, Nunan D, Heneghan CJ. Device-guided breathing exercises in the control of human blood pressure: systematic review and meta-analysis. J Hypertens. 2012;30(5):852–60. doi:10.1097/HJH.0b013e3283520077.
• Mahtani KR, Beinortas T, Bauza K, Nunan D. Device-guided breathing for hypertension: a summary evidence review. Curr Hypertens Rep. 2016;18(4):33. doi:10.1007/s11906-016-0631-z. A review that presents recent DGB clinical studies sponsored and not sponsored by the manufacturer and summarizes a recent meta-analysis previously published by some authors of this paper. DGB as a routine treatment is not recommended
van Hateren KJ, Landman GW, Logtenberg SJ, Bilo HJ, Kleefstra N. Device-guided breathing exercises for the treatment of hypertension: an overview. World J Cardiol. 2014;6(5):277–82. doi:10.4330/wjc. v6.i5.277.
Bhavanani A.B.,Madanmohan, and Sanjay Z. Immediate effect of chandra nadi pranayama (left unilateral forced nostril breathing) on cardiovascular parameters in hypertensive patients. Int J Yoga 2012; 5(2):108–111. doi: 10.4103/0973-6131. 98221.
Pramanik T, Sharma HO, Mishra S, Mishra A, Prajapati R, Singh S. Immediate effect of slow pace bhastrika pranayama on blood pressure and heart rate. J Altern Complement Med. 2009;15(3):293–5. doi:10.1089/acm. 2008.0440.
Wang SZ, Li S, Xu XY, Lin GP, Shao L, Zhao Y, et al. Effect of slow abdominal breathing combined with biofeedback on blood pressure and heart rate variability in prehypertension. J Altern Complement Med. 2010;16(10):1039–45. doi:10.1089/acm. 2009.0577.
Nakao M, Nomura S, Shimosawa T, Fujita T, Kuboki T. Blood pressure biofeedback treatment of white-coat hypertension. J Psychosom Res. 2000;48(2):161–9.
Yucha CB, Tsai PS, Calderon KS, Tian L. Biofeedback-assisted relaxation training for essential hypertension: who is most likely to benefit? J Cardiovasc Nurs. 2005;20(3):198–205.
Hartley L, Mavrodaris A, Flowers N, Ernst E, Barnes VA RK, Treiber FA, Johnson MH. Impact of transcendental meditation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014;12:CD010359.
Uddin AA, Morita PP, Tallevi K, Armour K, Li J, Nolan RP, Cafazzo JA. Development of a wearable cardiac monitoring system for behavioral neurocardiac training: a usability study. J MIR M health Uhealth. 2016;22(4(2)):e45. doi:10.2196/mhealth.5288.
Nolan RP, Floras JS, Harvey PJ, Kamath MV, Picton PE, Chessex C, Hiscock N, Powell J, Catt M, Hendrickx H, Talbot D, Chen MH. Behavioral neurocardiac training in hypertension: a randomized, controlled trial. Hypertension. 2010;55(4):1033–9. doi:10.1161/HYPERTENSIONAHA.109.146233.
Alabdulgader AA. Coherence: a novel nonpharmacological modality for lowering blood pressure in hypertensive patients. Glob Adv Health Med. 2012;1(2):56–64. doi:10.7453/gahmj.2012.1.2.011.
Vaschillo E, Lehrer P, Rishe N, Konstantinov M. Heart rate variability biofeedback as a method for assessing baroreflex function: a preliminary study of resonance in the cardiovascular system. Appl Psychophysiol Biofeedback. 2002;27(1):1–27.
•• Lehrer PM, Gevirtz R. Heart rate variability biofeedback: how and why does it work? Front Psychol. 2014;2(5):756. doi:10.3389/fpsyg. 2014.00756. A review that summarizes the possible mechanisms for the effectiveness of respiratory sinus arrhythmia
• Hering D, Kucharska W, Kara T, Somers VK, Parati G, Narkiewicz K. Effects of acute and long-term slow breathing exercise on muscle sympathetic nerve activity in untreated male patients with hypertension. J Hypertens. 2013;31(4):739–46. doi:10.1097/HJH.0b013e32835eb2cf. This recent trial demonstrates that DGB improves MSNA in short term and attenuates cardiovascular response to mental stress
Cramer H, Haller H, Lauche R, Steckhan N, Michalsen A, Dobos G. A systematic review and meta-analysis of yoga for hypertension. Am J Hypertens. 2014;27(9):1146–51. doi:10.1093/ajh/hpu 078.
Nidich SI, Rainforth MV, Haaga DA, Hagelin J, Salerno JW, Travis F, et al. A randomized controlled trial on effects of the Transcendental Meditation program on blood pressure, psychological distress, and coping in young adults. AmJ Hypertens. 2009;22(12):1326–31. doi:10.1038/ajh. 2009.184.
Wallen MP, Gomersall SR, Keating SE, Wisløff U, Coombes JS. Accuracy of heart rate watches: implications for weight management. PLoS One. 2016;11(5):e0154420. doi:10.1371/journal.pone.0154420. eCollection 2016
•• Brook RD, Jackson EA, Giorgini P, McGowan CL. When and how to recommend ‘alternative approaches’ in the management of high blood pressure. Am J Med. 2015;128(6):567–70. doi:10.1016/j.amjmed.2014.12.029. A review that presents who are hypertensive candidates for trials of alternative approaches, such as device-guided breathing and isometric handgrip
• Sica DA. Device-guided breathing and hypertension: a yet to be determined positioning. Am J Med. 2015;1208(6):567–70. An editorial that recommends device-guided breathing for several types of hypertensive patients
•• Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association. Hypertension. 2013;61(6):1360–83. doi:10.1161/HYP.0b013e318293645f. The American Heart Association confers a Class IIA, Level of Evidence B on device-guided breathing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
R.Z. served as a medical consultant to Intercure, the manufacturer of RESPeRATE, from March 21, 2013, until July 11, 2014. R.C. declares no conflict of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Device-Based Approaches for Hypertension
Rights and permissions
About this article
Cite this article
Cernes, R., Zimlichman, R. Role of Paced Breathing for Treatment of Hypertension. Curr Hypertens Rep 19, 45 (2017). https://doi.org/10.1007/s11906-017-0742-1
Published:
DOI: https://doi.org/10.1007/s11906-017-0742-1